01
PIONEERING THE FUTURE OF IMMUNOLOGY WITH NURAVAX
© 2024 Nuravax
Revolutionizing Healthcare with Breakthrough Vaccines for Alzheimer's and Beyond

Outline Nuravax's mission, emphasizing the innovative approach to developing preventive vaccines for Alzheimer's and other currently untreatable diseases
BIOTECH COMPANY
CONFRONTING CNS DISORDERS
At the forefront of neuroscience, we are steadfast in our commitment to oppose and cure central nervous system (CNS) diseases, with a primary focus on Alzheimer’s and Parkinson’s diseases. Our approach is at the cutting edge: We are developing a broad spectrum of therapeutic products based on our innovative MultiTEP platform. This advanced technological solution is designed to tackle the complex challenges scientists face in CNS disease research.
02
Advancing Neurological Health Through Innovative Vaccine Development

At Nuravax, our research pipeline is robust and forward-thinking, dedicated to developing vaccines for individuals at risk of Alzheimer’s disease, tauopathies, Parkinson’s disease, and other α-synucleopathies. Our projects are fueled by prestigious grants, including NIA and NINDS R21s, R01s, and U01 awards, reflecting the trust and recognition in our scientific community.
03
PIPELINE
PIPELINE
PUBLICATIONS
Showcasing Our Team's Research Excellence

Our team at Nuravax is not just at the forefront of developing innovative solutions for neurological diseases; we are also leading contributors to the scientific community. Our experts have a rich history of publishing an extensive array of studies, demonstrating our deep commitment to advancing knowledge in our field.
04
NEWS
05
NEWS
CONTACT
info@nuravax.com
06
5270 California Ave., Suite 300
Irvine, CA 92617
+16573659397